Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
Status:
Completed
Trial end date:
2001-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug and giving the drugs in different ways
may kill more tumor cells.
PURPOSE: Randomized phase II trial to compare the effectiveness of doxorubicin with
paclitaxel in treating women who have locally advanced breast cancer.